Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2013, Article ID 268625, 12 pages
http://dx.doi.org/10.1155/2013/268625
Research Article

Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification

1Inserm U1053, Université Bordeaux Segalen, 33076 Bordeaux Cedex, France
2Institute of Liver Studies, King’s College Hospital, London, UK
3National Taiwan University College of Medicine, Taipei, Taiwan
4National Taiwan University Hospital, Taipei, Taiwan
5Department of Pathology, University of California, San Francisco, CA 94143-0102, USA
6Department of Pathology, Mount Sinai School of Medicine, New York, NY 10029, USA
7Institute of Pathology, University Hospital, 69120 Heidelberg, Germany
8Department of Pathology, Yonsei University College of Medicine, P.O. Box 8044, Seoul, Republic of Korea
9Service d'Anatomie Pathologique, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, 1200 Brussels, Belgium
10Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
11Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, National University Hospital, National University Health System, Singapore 119074
12Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA
13Pathology Department, Hôpital Pellegrin, CHU Bordeaux, 33076 Bordeaux Cedex, France
14Inserm, UMR-674, Génomique Fonctionnelle des Tumeurs Solides, IUH, 75010 Paris, France
15Université Paris Descartes, Labex Immunooncology, Sorbonne Paris Cité, Faculté de Médecine, 75005 Paris, France

Received 5 November 2012; Accepted 25 December 2012

Academic Editor: Charissa Chang

Copyright © 2013 Charles Balabaud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Bioulac-Sage, G. Cubel, S. Taouji et al., “Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes,” American Journal of Surgical Pathology, vol. 36, no. 11, pp. 1691–1699, 2012. View at Publisher · View at Google Scholar
  2. S. Rebouissou, P. Bioulac-Sage, and J. Zucman-Rossi, “Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma,” Journal of Hepatology, vol. 48, no. 1, pp. 163–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Zucman-Rossi, E. Jeannot, J. T. Van Nhieu et al., “Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC,” Hepatology, vol. 43, no. 3, pp. 515–524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Shanbhogue, S. R. Prasad, N. Takahashi, R. Vikram, and D. V. Sahani, “Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management,” Radiology, vol. 258, no. 3, pp. 673–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Bioulac-Sage, C. Balabaud, P. Bedossa et al., “Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update,” Journal of Hepatology, vol. 46, no. 3, pp. 521–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Paradis, A. Benzekri, D. Dargére et al., “Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma,” Gastroenterology, vol. 126, no. 5, pp. 1323–1329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Paradis, A. Laurent, J. F. Flejou, M. Vidaud, and P. Bedossa, “Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation,” Hepatology, vol. 26, no. 4, pp. 891–895, 1997. View at Google Scholar · View at Scopus
  8. P. Bioulac-Sage, S. Rebouissou, A. Sa Cunha et al., “Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver,” Gastroenterology, vol. 128, no. 5, pp. 1211–1218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Rebouissou, G. Couchy, L. Libbrecht et al., “The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules,” Journal of Hepatology, vol. 49, no. 1, pp. 61–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Bioulac-Sage, S. Taouji, L. Possenti, and C. Balabaud, “Hepatocellular adenoma subtypes: the impact of overweight and obesity,” Liver International, vol. 32, no. 8, pp. 1217–1221, 2012. View at Publisher · View at Google Scholar
  11. V. Paradis, A. Champault, M. Ronot et al., “Telangiectatic adenoma: an entity associated with increased body mass index and inflammation,” Hepatology, vol. 46, no. 1, pp. 140–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Sasaki and Y. Nakanuma, “Overview of hepatocellular adenoma in Japan,” International Journal of Hepatology, vol. 2012, Article ID 648131, 6 pages, 2012. View at Publisher · View at Google Scholar
  13. H. Lin, J. Van Den Esschert, C. Liu, and T. M. Van Gulik, “Systematic review of hepatocellular adenoma in China and other regions,” Journal of Gastroenterology and Hepatology, vol. 26, no. 1, pp. 28–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Bioulac-Sage, H. Laumonier, and C. Balabaud, “Benign hepatocellular tumors,” in Practical Hepatic Pathology, R. Saxena, Ed., pp. 473–488, Elsevier Saunders, Philadelphia, Pa, USA, 2010. View at Google Scholar
  15. P. Bioulac-Sage, C. Balabaud, and I. Wanless, “Focal nodular hyperplasia and hepatocellular adenoma,” in Tumors of the Digestive Tract, World Health Organization, F. Bosman, F. Carneiro, R. Hruban, and N. D. Theise, Eds., pp. 198–204, IARC, Lyon France, 2nd edition, 2010. View at Google Scholar
  16. P. Bioulac-Sage, G. Cubel, C. Balabaud, and J. Zucman-Rossi, “Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers,” Seminars in Liver Disease, vol. 31, no. 1, pp. 91–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Bioulac-Sage, G. Cubel, and C. Balabaud, “Pathological diagnosis of hepatocellular adenoma in clinical practice,” Diagnostic Histopathology, vol. 17, no. 12, pp. 521–529, 2011. View at Publisher · View at Google Scholar
  18. P. Bioulac-Sage, S. Rebouissou, C. Thomas et al., “Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry,” Hepatology, vol. 46, no. 3, pp. 740–748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Bioulac-Sage, H. Laumonier, A. Rullier et al., “Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology,” Liver International, vol. 29, no. 3, pp. 459–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Van Der Borght, L. Libbrecht, A. Katoonizadeh et al., “Nuclear β-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy,” Histopathology, vol. 51, no. 6, pp. 855–856, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. F. Manichon, B. Bancel, M. Durieux-Millon et al., “Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions,” HPB Surgery, vol. 2012, Article ID 418745, 12 pages, 2012. View at Publisher · View at Google Scholar
  22. M. Sasaki, N. Yoneda, S. Kitamura, Y. Sato, and Y. Nakanuma, “Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience,” Hepatology Research, vol. 41, no. 10, pp. 982–988, 2011. View at Publisher · View at Google Scholar
  23. S. M. van Aalten, J. Verheij, T. Terkivatan, R. S. Dwarkasing, R. A. De Man, and J. N. M. Ijzermans, “Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice,” Journal of Hepatology, vol. 55, no. 1, pp. 120–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. O. C. Bellamy, R. S. Maxwell, S. Prost, I. A. Azodo, J. J. Powell, and J. R. Manning, “The value of imunophenotyping hepatocellular adenomas—consecutive resections at one UK centre,” Histopathology, vol. 62, no. 3, pp. 431–445, 2012. View at Publisher · View at Google Scholar
  25. P. Bioulac-Sage, H. Laumonier, G. Couchy et al., “Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience,” Hepatology, vol. 50, no. 2, pp. 481–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ronot, S. Bahrami, J. Calderaro et al., “Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification,” Hepatology, vol. 53, no. 4, pp. 1182–1191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Laumonier, P. Bioulac-Sage, C. Laurent, J. Zucman-Rossi, C. Balabaud, and H. Trillaud, “Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification,” Hepatology, vol. 48, no. 3, pp. 808–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. van Aalten, M. G. Thomeer, T. Terkivatan et al., “Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification,” Radiology, vol. 261, pp. 172–181, 2011. View at Publisher · View at Google Scholar
  29. M. Bieze, J. W. van den Esschert, C. Y. Nio et al., “Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium,” American Journal of Roentgenology, vol. 199, no. 1, pp. 26–34, 2012. View at Publisher · View at Google Scholar
  30. L. Grazioli, M. P. Bondioni, H. Haradome et al., “Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis,” Radiology, vol. 262, pp. 520–529, 2012. View at Publisher · View at Google Scholar
  31. H. Laumonier, H. Cailliez, C. Balabaud et al., “Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings,” American Journal of Roentgenology, vol. 199, no. 2, pp. 341–348, 2012. View at Publisher · View at Google Scholar
  32. T. Denecke, I. G. Steffen, S. Agarwal et al., “Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI,” European Radiology, vol. 22, no. 8, pp. 1769–1775, 2012. View at Publisher · View at Google Scholar
  33. J. W. van den Esschert, T. M. Van Gulik, and S. S. K. S. Phoa, “Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma,” Digestive Surgery, vol. 27, no. 1, pp. 46–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. V. S. Katabathina, C. O. Menias, A. K. Shanbhogue, J. Jagirdar, R. M. Paspulati, and S. R. Prasad, “Genetics and imaging of hepatocellular adenomas: 2011 update,” Radiographics, vol. 31, no. 6, pp. 1529–1543, 2011. View at Publisher · View at Google Scholar
  35. N. Yoneda, O. Matsui, A. Kitao et al., “Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8,” Japanese Journal of Radiology, vol. 30, no. 9, pp. 777–782, 2012. View at Publisher · View at Google Scholar
  36. S. Dokmak, V. Paradis, V. Vilgrain et al., “A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas,” Gastroenterology, vol. 137, no. 5, pp. 1698–1705, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. van Aalten, C. D. Witjes, R. A. de Man, J. N. Ijzermans, and T. Terkivatan, “Can a decision-making model be justified in the management of hepatocellular adenoma?” Liver International, vol. 32, no. 1, pp. 28–37, 2012. View at Publisher · View at Google Scholar
  38. T. Terkivatan and J. N. M. Ijzermans, “Hepatocellular adenoma: should phenotypic classification direct management?” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 697–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. van Aalten, M. E. Bröker, J. J. van Busschbach et al., “Pregnancy and liver adenoma management: PALM study,” BMC Gastroenterology, vol. 12, p. 82, 2012. View at Publisher · View at Google Scholar
  40. S. M. van Aalten, R. A. de Man, J. N. IJzermans, and T. Terkivatan, “Systematic review of haemorrhage and rupture of hepatocellular adenomas,” British Journal of Surgery, vol. 99, no. 7, pp. 911–916, 2012. View at Publisher · View at Google Scholar
  41. V. A. L. Huurman and A. F. M. Schaapherder, “Management of ruptured hepatocellular adenoma,” Digestive Surgery, vol. 27, no. 1, pp. 56–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. C. Bo and M. H. Nguyen, “The diagnosis and management of benign hepatic tumors,” Journal of Clinical Gastroenterology, vol. 39, no. 5, pp. 401–412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. F. Gibbs, A. M. Litwin, and M. S. Kahlenberg, “Contemporary management of benign liver tumors,” Surgical Clinics of North America, vol. 84, no. 2, pp. 463–480, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Chiche, T. Dao, E. Salamé et al., “Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature,” Annals of Surgery, vol. 231, no. 1, pp. 74–81, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Yoshidome, K. M. McMasters, and M. J. Edwards, “Management issues regarding hepatic adenomatosis,” American Surgeon, vol. 65, no. 11, pp. 1070–1076, 1999. View at Google Scholar · View at Scopus
  46. A. Perrakis, V. Muller, K. Oeckl et al., “Indications and long-term outcome after elective surgery for hepatocellular adenoma,” The American Surgeon, vol. 78, pp. 80–85, 2012. View at Google Scholar
  47. M. Abu Hilal, F. Di Fabio, R. D. Wiltshire, M. Hamdan, D. M. Layfield, and N. W. Pearce, “Laparoscopic liver resection for hepatocellular adenoma,” World Journal of Gastrointestinal Surgery, vol. 27, no. 3, pp. 101–105, 2011. View at Google Scholar
  48. M. Abu Hilal, F. Di Fabio, M. J. Teng, D. A. Godfrey, J. N. Primrose, and N. W. Pearce, “Surgical management of benign and indeterminate hepatic lesions in the era of laparoscopic liver surgery,” Digestive Surgery, vol. 28, pp. 232–236, 2011. View at Publisher · View at Google Scholar
  49. C. H. Wilson, D. M. Manas, and J. J. French, “Laparoscopic liver resection for hepatic adenoma in pregnancy,” Journal of Clinical Gastroenterology, vol. 45, no. 9, pp. 828–833, 2011. View at Publisher · View at Google Scholar
  50. S. Dardenne, C. Hubert, C. Sempoux et al., “Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 1337–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. J. F. Buell, H. Tranchart, R. Cannon, and I. Dagher, “Management of benign hepatic tumors,” Surgical Clinics of North America, vol. 90, no. 4, pp. 719–735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. G. Lopes Jr. and A. C. M. Duarte, “Clinical presentation and management of liver adenoma hemorrhagic complications,” American Surgeon, vol. 76, no. 6, pp. 654–655, 2010. View at Google Scholar · View at Scopus
  53. M. A. F. Ribeiro Junior, E. Chaib, W. A. Saad, L. A. C. D'Albuquerque, and I. Cecconello, “Surgical management of spontaneous ruptured hepatocellular adenoma,” Clinics, vol. 64, no. 8, pp. 775–779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. S. W. Cho, J. W. Marsh, J. Steel et al., “Surgical management of hepatocellular adenoma: take it or leave it?” Annals of Surgical Oncology, vol. 15, no. 10, pp. 2795–2803, 2008. View at Publisher · View at Google Scholar
  55. J. F. Gigot, C. Hubert, R. Banice, and M. L. Kendrick, “Laparoscopic management of benign liver diseases: where are we?” HPB Journal, vol. 6, no. 4, pp. 197–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Toso, P. Majno, A. Andres et al., “Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors,” World Journal of Gastroenterology, vol. 11, no. 36, pp. 5691–5695, 2005. View at Google Scholar · View at Scopus
  57. K. J. Evason, J. P. Grenert, L. D. Ferrell, and S. Kakar, “Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas,” Human Pathology, 2012. View at Publisher · View at Google Scholar
  58. J. H. Stoot, R. J. Coelen, M. C. De Jong, and C. H. Dejong, “Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases,” HPB Journal, vol. 12, no. 8, pp. 509–522, 2010. View at Google Scholar · View at Scopus
  59. O. Farges, N. Ferreira, S. Dokmak et al., “Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver,” Clinical Radiology, vol. 67, no. 4, pp. 329–333, 2012. View at Publisher · View at Google Scholar
  60. M. Sasaki, N. Yoneda, S. Kitamura, Y. Sato, and Y. Nakanuma, “A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor,” Modern Pathology, vol. 25, no. 12, pp. 1584–1593, 2012. View at Publisher · View at Google Scholar